More than 20 fusion partners of ALK have been identified in NSCLC, with the EML4-ALK fusion being the most common and ALK translocations present in approximately 3% - 5% of patients with non-squamous NSCLC, who are mostly young women who are light or have never smoked (3–5). The gene discussed is EML4; the disease is non-small cell lung carcinoma.